Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC
- Status
- WITHDRAWN
- Phase
- NA
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC
- Status
- COMPLETED
- Phase
- PHASE1
Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency
- Status
- UNKNOWN
- Phase
- PHASE3